Wearable drug delivery devices are single-use systems that are comfortably worn on the body while the drug is subcutaneously administered over a pre-programmed period spanning seconds or hours. Upon full injection of the dose, they are removed from the body and conveniently disposed.
The global Wearable Drug Delivery Devices market was valued at US$ 5413 million in 2023 and is anticipated to reach US$ 10550 million by 2030, witnessing a CAGR of 10.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Wearable Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Drug Delivery Devices.
Report Scope
The Wearable Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wearable Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wearable Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
West Pharma
Unilife Corporation
CeQur
BD
Enable Injections
Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Eitan Medical
Noble International
Insulet
Amgen
Roche
ScPharmaceuticals
Segment by Type
Electronical Drug Delivery Devices
Mechanical Drug Delivery Devices
Segment by Application
Immuno-Oncology
Diabetes
Cardiovascular Diseases
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Wearable Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Wearable Drug Delivery Devices
1.2 Wearable Drug Delivery Devices Segment by Type
1.2.1 Global Wearable Drug Delivery Devices Market Value Comparison by Type (2024-2030)
1.2.2 Electronical Drug Delivery Devices
1.2.3 Mechanical Drug Delivery Devices
1.3 Wearable Drug Delivery Devices Segment by Application
1.3.1 Global Wearable Drug Delivery Devices Market Value by Application: (2024-2030)
1.3.2 Immuno-Oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Others
1.4 Global Wearable Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Wearable Drug Delivery Devices Revenue 2019-2030
1.4.2 Global Wearable Drug Delivery Devices Sales 2019-2030
1.4.3 Global Wearable Drug Delivery Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Wearable Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Wearable Drug Delivery Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Wearable Drug Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Wearable Drug Delivery Devices Average Price by Manufacturers (2019-2024)
2.4 Global Wearable Drug Delivery Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Wearable Drug Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wearable Drug Delivery Devices, Product Type & Application
2.7 Wearable Drug Delivery Devices Market Competitive Situation and Trends
2.7.1 Wearable Drug Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Wearable Drug Delivery Devices Players Market Share by Revenue
2.7.3 Global Wearable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Wearable Drug Delivery Devices Retrospective Market Scenario by Region
3.1 Global Wearable Drug Delivery Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Wearable Drug Delivery Devices Global Wearable Drug Delivery Devices Sales by Region: 2019-2030
3.2.1 Global Wearable Drug Delivery Devices Sales by Region: 2019-2024
3.2.2 Global Wearable Drug Delivery Devices Sales by Region: 2025-2030
3.3 Global Wearable Drug Delivery Devices Global Wearable Drug Delivery Devices Revenue by Region: 2019-2030
3.3.1 Global Wearable Drug Delivery Devices Revenue by Region: 2019-2024
3.3.2 Global Wearable Drug Delivery Devices Revenue by Region: 2025-2030
3.4 North America Wearable Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Wearable Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Wearable Drug Delivery Devices Sales by Country (2019-2030)
3.4.3 North America Wearable Drug Delivery Devices Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Wearable Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Wearable Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Wearable Drug Delivery Devices Sales by Country (2019-2030)
3.5.3 Europe Wearable Drug Delivery Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wearable Drug Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Wearable Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Wearable Drug Delivery Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Wearable Drug Delivery Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Wearable Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Wearable Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Wearable Drug Delivery Devices Sales by Country (2019-2030)
3.7.3 Latin America Wearable Drug Delivery Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wearable Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Wearable Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Wearable Drug Delivery Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Wearable Drug Delivery Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Wearable Drug Delivery Devices Sales by Type (2019-2030)
4.1.1 Global Wearable Drug Delivery Devices Sales by Type (2019-2024)
4.1.2 Global Wearable Drug Delivery Devices Sales by Type (2025-2030)
4.1.3 Global Wearable Drug Delivery Devices Sales Market Share by Type (2019-2030)
4.2 Global Wearable Drug Delivery Devices Revenue by Type (2019-2030)
4.2.1 Global Wearable Drug Delivery Devices Revenue by Type (2019-2024)
4.2.2 Global Wearable Drug Delivery Devices Revenue by Type (2025-2030)
4.2.3 Global Wearable Drug Delivery Devices Revenue Market Share by Type (2019-2030)
4.3 Global Wearable Drug Delivery Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Wearable Drug Delivery Devices Sales by Application (2019-2030)
5.1.1 Global Wearable Drug Delivery Devices Sales by Application (2019-2024)
5.1.2 Global Wearable Drug Delivery Devices Sales by Application (2025-2030)
5.1.3 Global Wearable Drug Delivery Devices Sales Market Share by Application (2019-2030)
5.2 Global Wearable Drug Delivery Devices Revenue by Application (2019-2030)
5.2.1 Global Wearable Drug Delivery Devices Revenue by Application (2019-2024)
5.2.2 Global Wearable Drug Delivery Devices Revenue by Application (2025-2030)
5.2.3 Global Wearable Drug Delivery Devices Revenue Market Share by Application (2019-2030)
5.3 Global Wearable Drug Delivery Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 West Pharma
6.1.1 West Pharma Corporation Information
6.1.2 West Pharma Description and Business Overview
6.1.3 West Pharma Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 West Pharma Wearable Drug Delivery Devices Product Portfolio
6.1.5 West Pharma Recent Developments/Updates
6.2 Unilife Corporation
6.2.1 Unilife Corporation Corporation Information
6.2.2 Unilife Corporation Description and Business Overview
6.2.3 Unilife Corporation Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Unilife Corporation Wearable Drug Delivery Devices Product Portfolio
6.2.5 Unilife Corporation Recent Developments/Updates
6.3 CeQur
6.3.1 CeQur Corporation Information
6.3.2 CeQur Description and Business Overview
6.3.3 CeQur Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CeQur Wearable Drug Delivery Devices Product Portfolio
6.3.5 CeQur Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BD Wearable Drug Delivery Devices Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Enable Injections
6.5.1 Enable Injections Corporation Information
6.5.2 Enable Injections Description and Business Overview
6.5.3 Enable Injections Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Enable Injections Wearable Drug Delivery Devices Product Portfolio
6.5.5 Enable Injections Recent Developments/Updates
6.6 Gerresheimer
6.6.1 Gerresheimer Corporation Information
6.6.2 Gerresheimer Description and Business Overview
6.6.3 Gerresheimer Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Gerresheimer Wearable Drug Delivery Devices Product Portfolio
6.6.5 Gerresheimer Recent Developments/Updates
6.7 Owen Mumford
6.6.1 Owen Mumford Corporation Information
6.6.2 Owen Mumford Description and Business Overview
6.6.3 Owen Mumford Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Owen Mumford Wearable Drug Delivery Devices Product Portfolio
6.7.5 Owen Mumford Recent Developments/Updates
6.8 Sonceboz
6.8.1 Sonceboz Corporation Information
6.8.2 Sonceboz Description and Business Overview
6.8.3 Sonceboz Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sonceboz Wearable Drug Delivery Devices Product Portfolio
6.8.5 Sonceboz Recent Developments/Updates
6.9 United Therapeutics
6.9.1 United Therapeutics Corporation Information
6.9.2 United Therapeutics Description and Business Overview
6.9.3 United Therapeutics Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 United Therapeutics Wearable Drug Delivery Devices Product Portfolio
6.9.5 United Therapeutics Recent Developments/Updates
6.10 Ypsomed
6.10.1 Ypsomed Corporation Information
6.10.2 Ypsomed Description and Business Overview
6.10.3 Ypsomed Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ypsomed Wearable Drug Delivery Devices Product Portfolio
6.10.5 Ypsomed Recent Developments/Updates
6.11 Elcam Medical
6.11.1 Elcam Medical Corporation Information
6.11.2 Elcam Medical Wearable Drug Delivery Devices Description and Business Overview
6.11.3 Elcam Medical Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elcam Medical Wearable Drug Delivery Devices Product Portfolio
6.11.5 Elcam Medical Recent Developments/Updates
6.12 Eitan Medical
6.12.1 Eitan Medical Corporation Information
6.12.2 Eitan Medical Wearable Drug Delivery Devices Description and Business Overview
6.12.3 Eitan Medical Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Eitan Medical Wearable Drug Delivery Devices Product Portfolio
6.12.5 Eitan Medical Recent Developments/Updates
6.13 Noble International
6.13.1 Noble International Corporation Information
6.13.2 Noble International Wearable Drug Delivery Devices Description and Business Overview
6.13.3 Noble International Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Noble International Wearable Drug Delivery Devices Product Portfolio
6.13.5 Noble International Recent Developments/Updates
6.14 Insulet
6.14.1 Insulet Corporation Information
6.14.2 Insulet Wearable Drug Delivery Devices Description and Business Overview
6.14.3 Insulet Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Insulet Wearable Drug Delivery Devices Product Portfolio
6.14.5 Insulet Recent Developments/Updates
6.15 Amgen
6.15.1 Amgen Corporation Information
6.15.2 Amgen Wearable Drug Delivery Devices Description and Business Overview
6.15.3 Amgen Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Amgen Wearable Drug Delivery Devices Product Portfolio
6.15.5 Amgen Recent Developments/Updates
6.16 Roche
6.16.1 Roche Corporation Information
6.16.2 Roche Wearable Drug Delivery Devices Description and Business Overview
6.16.3 Roche Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Roche Wearable Drug Delivery Devices Product Portfolio
6.16.5 Roche Recent Developments/Updates
6.17 ScPharmaceuticals
6.17.1 ScPharmaceuticals Corporation Information
6.17.2 ScPharmaceuticals Wearable Drug Delivery Devices Description and Business Overview
6.17.3 ScPharmaceuticals Wearable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.17.4 ScPharmaceuticals Wearable Drug Delivery Devices Product Portfolio
6.17.5 ScPharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wearable Drug Delivery Devices Industry Chain Analysis
7.2 Wearable Drug Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wearable Drug Delivery Devices Production Mode & Process
7.4 Wearable Drug Delivery Devices Sales and Marketing
7.4.1 Wearable Drug Delivery Devices Sales Channels
7.4.2 Wearable Drug Delivery Devices Distributors
7.5 Wearable Drug Delivery Devices Customers
8 Wearable Drug Delivery Devices Market Dynamics
8.1 Wearable Drug Delivery Devices Industry Trends
8.2 Wearable Drug Delivery Devices Market Drivers
8.3 Wearable Drug Delivery Devices Market Challenges
8.4 Wearable Drug Delivery Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
West Pharma
Unilife Corporation
CeQur
BD
Enable Injections
Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Eitan Medical
Noble International
Insulet
Amgen
Roche
ScPharmaceuticals
听
听
*If Applicable.
